Citius Oncology (CTOR) Gross Profit (2025 - 2026)

Citius Oncology (CTOR) recorded quarterly Gross Profit of $1.3 million in Q1 2026, down 57.58% quarter-over-quarter from $3.2 million in Q4 2025.

Citius Oncology (CTOR) Gross Profit (2025 - 2026) Analysis & Trends

Citius Oncology's Gross Profit history runs 2 years deep, the most recent figure standing at $1.3 million for Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Citius Oncology	75.12 Mn	72.49 Mn	1.34 Mn

Download Data